AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information; Extension of Comment Period

Federal Register US Published: 2026-05-28 00:00:00

Full text

The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice entitled "AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information" that appeared in the Federal Register of April 29, 2026. In the notice, FDA requested comments to solicit input on a proposed pilot program to assess how artificial intelligence (AI)-enabled technologies can improve efficiency, speed, and quality of decision- making in early phase clinical trials. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.

Open Source →

Recommended reads

U.S. Copyright Office Announces Start of Tenth Triennial Rulemaking Proceeding Under Section 1201 From US

U.S. Copyright Office Announces Start of Tenth Triennial Rulemaking Proceeding Under Section 1201 NewsNet 1088 June 9, 2026 The Copyright Office has published a notice of inquiry and request for petit…

U.S. Copyright Office — NewsNet · US 2026-06-09

U.S. Copyright Office Issues Final Rule Redesignating Mechanical Licensing Collective and Digital Licensee Coordinator Under the Music Modernization Act From US

U.S. Copyright Office Issues Final Rule Redesignating Mechanical Licensing Collective and Digital Licensee Coordinator Under the Music Modernization Act NewsNet 1087 June 03, 2026 The Register has det…

U.S. Copyright Office Proposes an Amendment to the Group Registration Option for Updates to News Websites From US

U.S. Copyright Office Proposes an Amendment to the Group Registration Option for Updates to News Websites NewsNet 1086 May 28, 2026 The U.S. Copyright Office proposes an amendment to the group registr…